| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Inozyme Pharma (NASDAQ:INZY) reported its Q4 earnings results on Tuesday, March 12, 2024 at 08:30 AM.
Here's what investors need to know about the announcement.
Inozyme Pharma missed estimated earnings by -3.0%, reporting an EPS of $-0.33 versus an estimate of $-0.32.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.03 which was followed by a 3.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Inozyme Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: INZY
